Détail de l'éditeur
Documents disponibles chez cet éditeur (463)
Rapport
This report provides a comprehensive overview of the methamphetamine market in the European Union. It assesses the current threat situation regarding current trends in production, trafficking and distribution.Rapport
G. HAY ; N. McKEGANEY ; L. WIESSING ; R. HARTNOLL ; P. Y. BELLO ; D. D'IPPOLITI ; A. DOMINGO-SALVANY ; M. FRISCHER ; L. KRAUS ; F. SMIT | Lisbon : OEDT / EMCDDA | 1999'How many people use illicit drugs?' is a question which is deceptively easy to ask but notoriously difficult to answer. To examine the tools which were available to answer this question a scientific seminar was organised by the European Monitor[...]Rapport
OEDT = EMCDDA ; D. M. WOOD ; P. I. DARGAN | Lisbon : OEDT / EMCDDA | Risk assessments, ISSN 1725-4493 | 2014This report presents the data and findings of the risk assessment on the new psychoactive substance, 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine), that was conducted by the Scientific Committee of the EMCDDA. Concerns over t[...]Rapport
This publication presents the data and findings of the risk assessment on 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 21 March 2018. O[...]Document multimédia
This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide. It provides an overview of the most important aspects to consider when planning or delivering health and social respon[...]Rapport
Unusually high numbers of migrants have moved to Europe in recent years, with about 1.2 million people applying for asylum in the European Union in each of the years 2015 and 2016. Fears have been expressed that this group's health status and po[...]Livre
C. GODFREY ; L. WIESSING ; R. HARTNOLL, Éditeur scientifique | Lisbon : OEDT / EMCDDA | Monographs, ISSN 1606-1691 | 2001FRANÇAIS : La modélisation est un moyen technique de simplifier des processus complexes. Ceci est accompli grâce à l'informatique et l'utilisation de formules mathématiques décrivant de manière quantitative les éléments constituant le processu[...]Rapport
A better understanding of the complex science of 'addiction' can improve responses to drug problems. This report contains a critical review of existing addiction theories and explores how these can be organised into an overarching structure to i[...]Rapport
This report provides an overview of the changes in cannabis policies in the Americas and the evidence emerging from evaluations of their impact. Highlighting the challenges in monitoring and evaluating regulatory changes in the drugs field, it w[...]Rapport
FRANÇAIS : Ce rapport explore la manière dont, à travers des enquêtes sur des populations ciblées, sont recueillies des données sur l'usage de drogues dans l'espace récréatif public (pubs, bars, clubs, scènes musicales) et privé en Europe. Il r[...]Rapport
J. WALDRON ; M. GRABSKI ; ALAMA Consortium | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2022Given the lack of contemporary longitudinal data that acknowledges recent market developments, there is an urgent need to develop and validate methods to investigate the relationship between drug use and engagement with the nightlife scene in Eu[...]Rapport
This paper looks at the implementation and recruitment strategies of the 2016 European Web Survey on Drugs (EWSD) in France. It also explores the possibility of generalising the EWSD results by using a matching procedure that links EWSD responde[...]Rapport
J. P. CAULKINS ; K. FURLONG ; B. McCOMAS ; M. NOGUEIRA DOMINGUES ; A. SIDDIQUE ; B. KILMER | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2022This chapter explores two methods of bringing together the complementary strengths of general population surveys (GPS) and web surveys to develop improved estimates of overall quantities of drugs consumed — namely, raking and regression. Raking [...]Rapport
In recent years the European MDMA market has been characterised by the increasing availability of high-strength products, resulting in a number of deaths. Most studies documenting the patterns and trends in use of this stimulant have grouped tab[...]Rapport
This paper describes the development and results of a web survey, named the Party Panel, that addresses emerging risks in nightlife settings. The survey does so by gathering the information that prevention organisations require to develop theory[...]Rapport
This paper assesses data quality in the first two rounds of the European Web Survey on Drugs (EWSD). Data quality has various dimensions, such as accuracy, consistency, validity and completeness, but can be defined as fitness of the data for the[...]Rapport
A substantial amount of research has focused on understanding the sources from which individuals acquire illicit substances. To contribute to this area of research, the European Web Survey on Drugs (EWSD) included several questions to assess whe[...]Rapport
This paper presents some of the key findings of an innovative online survey of cannabis growers in Europe, Australia and North America. The International Cannabis Cultivation Questionnaire (ICCQ) presents generated important findings about canna[...]Rapport
This paper considers two different ways in which web surveys might be used to provide insights concerning those people who purchase drugs on cryptomarkets. First, data from the second wave of the European Web Survey on Drugs (EWSD) are analysed [...]Rapport
A. R. WINSTOCK ; E. L. DAVIES ; J. A. FERRIS ; L. J. MAIER ; M. J. BARRATT | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2022The Global Drug Survey (GDS) is a detailed annual online survey of psychoactive substance use that first ran in 2011. The 10 GDS surveys to date have collected data from more than 900 000 respondents, containing information that can answer key a[...]Rapport
Differences in drug market conditions, for which data are often limited, can have important implications for the health and social harms of drug use and the related responses by relevant agencies in this field. A key component of monitoring illi[...]Rapport
This paper provides a narrative review of the existing literature around online survey methods and their specific application in the area of illicit drug use. A search of relevant databases (Google Scholar, EBSCO, ProQuest) was conducted in orde[...]Rapport
This technical report focuses on an elimination barometer for viral hepatitis to help countries assess progress towards eliminating hepatitis C and B among people who inject drugs (PWID). The barometer is being developed by the EMCDDA together w[...]Rapport
L. LANIEL ; C. CARPENTIER ; C. COSTA STORTI ; D. LOPEZ ; C. MARTEL ; L. ROYUELA ; R. SEDEFOV ; J. WRIGHT ; F. ZOBEL ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Technical Datasheets, ISSN 1831-2314 | 2008Growing cocaine use in several EU countries, and increased seizures of cocaine on air, sea and land routes, have become subjects of increasing concern to policymakers. This datasheet provides a short review of key issues relating to how cocaine [...]Rapport
L. LANIEL ; D. LOPEZ ; J. WRIGHT ; C. CARPENTIER ; D. MANSFIELD ; L. ROYUELA ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Technical Datasheets, ISSN 1831-2314 | 2008ENGLISH : In recent years, anxiety in Europe has increased about the impact of record opium harvests in Afghanistan, and a decrease in heroin retail prices. This datasheet provides a condensed review of the key issues about how heroin manufact[...]Rapport
Drug-related mortality is a complex phenomenon, which accounts for a considerable percentage of deaths among young people in many European countries. The EMCDDA, in collaboration with national experts, has defined an epidemiological indicator wi[...]Rapport
OEDT = EMCDDA ; I. GIRAUDON ; M. BUSTER ; A. ESPELT ; J. MATIAS ; J. VICENTE | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2015This paper examines the overall number of lives lost due to drug use. All-cause mortality among problem drug users is investigated by means of cohort studies, which link data from death registries to drug treatment records. Building on earlier w[...]Rapport
C. A. PERUCCI ; A. M. BARGAGLI ; M. DAVOLI ; SPERATI A. ; R. HARTNOLL ; J. VICENTE | Lisbon : OEDT / EMCDDA | Scientific Reports | 2005ENGLISH : Since 1996, the Department of Epidemiology ASL RM E, Rome, Italy has been coordinating a project promoted by the EMCDDA, aimed to produce and compare mortality rates estimates across European countries by the implementation of coho[...]Rapport
This Selected issue focuses on mortality among drug users due to all causes, of which drug-induced deaths (overdoses) is only a component, albeit the one most well-documented. The publication begins with an introduction to mortality cohort studi[...]Rapport
This publication presents the data and findings of the risk assessment on MT-45 (1-cyclohexyl-4-(1, 2-diphenylethyl)piperazine), carried out by the extended Scientific Committee of the EMCDDA on 16 September 2014. The main part of the publicatio[...]Rapport
OEDT = EMCDDA ; F. FAGGIANO ; R. MOLINAR | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2014During adolescence, some young people may experiment with both licit and illicit substances (alcohol, tobacco, cannabis and other drugs). This can have an impact on their behaviour, their relationships with others and how they function in societ[...]Rapport
FRANÇAIS : Cette « Question particulière » de l'OEDT concernant la recherche nationale en matière de drogue en Europe décrit brièvement le cadre dans lequel la recherche en matière de drogue est menée dans les pays européens. Elle examine plus[...]Rapport
OEDT = EMCDDA ; V. AUWÄRTER ; J. DE MORAIS ; A. GALLEGOS ; M. EVANS-BROWN ; R. CHRISTIE ; R. JORGE ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Rapid communication | 2021This report provides a technical review of the current body of knowledge regarding new benzodiazepines that are monitored by the EU Early Warning System. The aims of this report are to strengthen situational awareness of new benzodiazepines in E[...]Rapport
As more jurisdictions contemplate and pass laws to legalise cannabis for medical and non-medical purposes, the discussions about cannabis policy will likely become more intense in the EU. Member States can learn from these experiences and decide[...]Rapport
This paper gives an overview of some recent developments in the tools most commonly used to manage national drug policies: strategies, coordination mechanisms and evaluations. It is based on an analysis of reports on national drug policies compi[...]Rapport
The prescription of substitution drugs, such as methadone and buprenorphine, has become a mainstream, first-line treatment for opioid dependence, with around 700 000 of Europe's 1.3 million problem opioid users receiving substitution treatment t[...]Rapport
This update from the EU Early Warning System overviews the NPS situation in Europe in 2020-2021 and highlights emerging threats to support early warning, preparedness planning and response measures. In addition, it reflects on the changes and th[...]Rapport
OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; R. CHRISTIE ; R. JORGE ; J. DE MORAIS ; A. ALMEIDA ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Rapid communication | 2020In this update from the the EU Early Warning System aims to provide insights into what is happening with new psychoactive substances in Europe, based on data from the agency's early warning and risk-assessment activities. The report covers the p[...]Rapport
OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; W. FRANCIS ; R. CHRISTIE ; A. CUNNINGHAM ; J. SEKULA ; A. ALMEIDA ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Rapid communication | 2015FRANÇAIS : De nouvelles substances psychoactives (NSP ou «nouvelles drogues») ont été détectées dans l'Union européenne l'année dernière au rythme de deux par semaine environ. Au total, 101 nouvelles substances ont été signalées au système d'al[...]Rapport
This short report provides an overview of how European countries are developing innovative legal responses to the challenges presented to public health and drug policy by the rapidly evolving market for new psychoactive substances.Rapport
The European new psychoactive substances (NPS) market has increased at a speed that established drug control laws struggle to match. Various countries have therefore introduced new legal responses to this phenomenon, based either on existing law[...]Rapport
OEDT = EMCDDA ; L. VANDAM ; P. BORLE ; L. MONTANARI ; T. SURMONT ; A. PIRONA ; D. HEDRICH ; A. GALLEGOS ; N. SINGLETON ; J. MOUNTENEY ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Rapid communication | 2018This report looks at the use of new psychoactive substances (NPS) in prison settings. This is a rapidly developing phenomenon, but empirical data are currently scarce and patchy. There is growing evidence that NPS are responsible for a large sha[...]Rapport
P. GRIFFITHS ; L. VINGOE ; K. JANSEN ; J. SHERVAL ; R. LEWIS ; R. HARTNOLL ; M. NILSON | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 1997FRANÇAIS : Ce rapport rend compte des résultats de deux études, commissionnées par l'OEDT, menées par le National Addiction Centre (Londres) et le Centre for HIV/AIDS and Drug Studies (Edinbourg). Le terme de drogues synthétiques fait référenc[...]Rapport
G. BURKHART, Auteur ; J. FOUNTAIN, Éditeur scientifique | Lisbon : OEDT / EMCDDA | Thematic Papers, ISSN 1725-5767 | 2013Some commentators argue that programmes developed in North America (Canada and the US) are unlikely to work in European countries, due to differing cultural contexts and because most of the evidence for their effectiveness comes from North Ameri[...]Rapport
P. GRIFFITHS ; L. VINGOE ; K. JANSEN ; J. SHERVAL ; R. LEWIS ; R. HARTNOLL ; M. NILSON | Lisbon : OEDT / EMCDDA | 1997Document multimédia
FRANÇAIS : Ce mini-guide s'inscrit dans le cadre plus vaste du document intitulé "Réponses sanitaires et sociales apportées aux problèmes de drogue : un guide européen". Il fournit une vue d'ensemble des aspects les plus importants à prendre en[...]Rapport
FRANÇAIS : Ce court rapport (« snapshot ») porte sur la vente en ligne de nouvelles substances psychoactives. Alors que 170 magasins en ligne vendant de nouvelles substances psychoactives (« legal high ») et livrant à au moins un pays membre de[...]Document multimédia
This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide. It provides an overview of the most important aspects to consider when planning or delivering health and social respon[...]Rapport
D. J. KORF ; H. RIPER ; M. FREEMAN ; R. LEWIS ; I. GRANT ; E. JACOB ; C. MOUGIN ; M. NILSON | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 1999FRANÇAIS : On observe des différences significatives à l'intérieur de l'Europe dans le travail de proximité avec les usagers de drogues tant dans les fondements théoriques, politiques, sociaux et pratiques que dans la façon dont ces activités [...]Rapport
This report presents an analysis of the drug markets in the European Neighbourhood Policy-East region covering Armenia, Azerbaijan, Belarus, Georgia, Moldova and Ukraine. Focused on providing insights into drug production, trafficking, sale, use[...]Rapport
This report presents an analysis of the drug markets in the European Neighbourhood Policy-South region covering Algeria, Egypt, Israel, Jordan, Lebanon, Libya, Morocco, Palestine, Syria and Tunisia. Focused on providing insights into drug produc[...]Rapport
This document is a summary of the concepts and definitions in the revised area. Detailed background information about the process of revision can be found in two related documents. The changes are, for the most part, related to the theoretical c[...]Document multimédia
The use of mass media campaigns as a drug prevention intervention is relatively common, but it is not without controversy. Both policymakers and practitioners have debated the effectiveness of such campaigns in reducing drug use among young peop[...]Document multimédia
The European market for hashish is currently one of the world's largest and most profitable. About 647 tons of cannabis herb and 641 tons of hashish were consumed in the European Union in 2013 and the retail market has an overall value estimated[...]Document multimédia
Cannabis is Europe's most commonly used illicit drug, with approximately 20 million adults, or around 6% of the population aged 15-64 years, having used the drug in the last year. An indication of the public health impact of the drug can be seen[...]Document multimédia
Cocaine is Europe's most commonly used illicit stimulant drug, with about 3.6 million adults (aged 15-64) estimated to have used it in the last year. It is the second most seized drug in Europe, after cannabis. Cocaine is trafficked to Europe fr[...]Document multimédia
Comorbidity of substance use and mental health disorders refers to the co-occurrence of a substance use disorder and another mental health disorder in the same individual. In Europe, the presence of psychiatric disorders associated with substanc[...]Document multimédia
FRANÇAIS : Les salles de consommation de drogues à moindre risque dans lesquelles des drogues illicites peuvent être consommées sous la supervision de personnel qualifié, existent en Europe depuis une trentaine d'années. Ces infrastructures ont[...]Document multimédia
Every year, several thousands of cocaine-related emergencies are reported in Europe, along with hundreds of cocaine-related deaths. The types of cocaine-related problems reported are wide-ranging and the relatively high prevalence of cocaine use[...]Document multimédia
Methamphetamine is an established stimulant drug in many parts of the world (e.g. South-east Asia, US), where it has long caused major public health problems. While methamphetamine use in Europe has historically been confined to the Czech Republ[...]Document multimédia
The emergence of new psychoactive substances (NPS) over the last decade has posed a major challenge to drug policy. While the limited available data indicates that prevalence levels of NPS use are relatively low in the general European populatio[...]Document multimédia
Hepatitis C is the most common infectious disease in injecting drug users, among whom it is usually transmitted through the sharing of injecting equipment such as needles and syringes. Most of those who become infected go on to develop chronic H[...]Document multimédia
Over 50 synthetic cathinone derivatives were detected via the EU Early Warning System (EU-EWS) between 2005 and 2013. This 'Perspective on drugs' explores new worrying localised and national outbreaks of injecting these substances and recommends[...]Document multimédia
The Internet is now recognised as a plausible vehicle for delivering drug and alcohol education, prevention and treatment programmes in a range of settings. This 'Perspective on drugs' charts developments in Internet-based drug treatment (IBDT),[...]Document multimédia
Recent years have witnessed a proliferation of new psychoactive substances becoming available in Europe. This can be illustrated through the rise in notifications of new substances to the EU early warning system, from just 14 per year in 2005 to[...]Document multimédia
FRANÇAIS : Trois conventions des Nations unies constituent le cadre juridique international pour le contrôle des drogues illicites. Elles recommandent aux pays de restreindre l'offre de drogues et de limiter leur utilisation à des fins médicale[...]Document multimédia
Europe has long been one of the world's largest consumer markets for cannabis, particularly resin imported mainly from Morocco. In this analysis, we report how Europe's consumer market for cannabis is increasingly dominated by herbal products, w[...]Document multimédia
FRANÇAIS : L'héroïne est traditionnellement importée en Europe sous deux formes, la plus courante étant l'héroïne brune (forme chimique base), produite essentiellement en Afghanistan et dans d'autres pays de l'Asie du Sud-Est. L'héroïne blanche[...]Document multimédia
More than 9 000 lives were reported to be lost to drug overdoses in Europe (28 EU Member States, Turkey and Norway) in 2016, the latest reporting year, and this is an underestimate. Reducing drug-related deaths therefore remains a major challeng[...]Document multimédia
The use of substitution drugs for the treatment of opioid dependence represents a key evidence-based response to heroin problems in Europe. However, the diversion of these medicines from their intended use in drug treatment to non-medical use an[...]Document multimédia
FRANÇAIS : Les cannabinoïdes de synthèse représentent le plus grand groupe de substances actuellement suivies en Europe par l'EMCDDA grâce au système d'alerte rapide de l'UE. Cette analyse présente les connaissances actuelles sur ces substances[...]Document multimédia
Synthetic drugs have been produced illicitly in Europe for over 40 years and, by global standards, Europe remains a significant producer today. Described in this analysis are current trends in illicit synthetic drug production in Europe and some[...]Document multimédia
Benzodiazepines are a widely prescribed group of medicines with a range of clinical uses, including the treatment of anxiety and insomnia and the management of alcohol withdrawal. For a number of reasons this group of medicines are often misused[...]Document multimédia
On the basis of an external evaluation of the EU drugs strategy 2005-12, on 7 December 2012 the Justice and Home Affairs Council of the European Union endorsed a new EU drugs strategy (2013-20). The strategy was designed to be implemented by two[...]Document multimédia
Psychosocial interventions are structured psychological or social interventions used to address substance-related problems. They can be used at different stages of drug treatment to identify the problem, treat it and assist with social reintegra[...]Document multimédia
The EMCDDA has carried out a meta-analysis of six reviews examining the effectiveness of medications used in treating cocaine problems. The original reviews, undertaken by the Cochrane Drugs and Alcohol Group, involved 92 studies (85 in the US) [...]Document multimédia
Perspectives on drugs (PODs) Trends in heroin use in Europe - what do treatment demand data tell us?
The current number of problem opioid users in Europe can be estimated at about 1.4 million, or 0.41% of the adult population, with heroin being by far the most widely used opioid. Heroin use has developed along different timelines; several weste[...]Document multimédia
The findings of the largest European project to date in the emerging science of wastewater analysis are taken up in this 'Perspective on drugs'. The project in question analysed wastewater in 82 European cities and towns to explore the drug-taki[...]Rapport
ENGLISH : This is the final report of a pilot project to describe and analyse local drug markets was started in September 1999 and carried out throughout 2000 in Frankfurt (Germany) and Milan (Italy). Data for the study were primarily gathere[...]Rapport
ENGLISH : How problem drug use develops over time in Europe is only known through indirect indicators - such as treatment presentations, drug seizures or drug related deaths - and from a limited number of cities. Estimates of the incidence of [...]Rapport
C. COSTA STORTI, Coordonnateur ; OEDT = EMCDDA | Lisbon : OEDT / EMCDDA | Thematic Papers, ISSN 1725-5767 | 2011The European Union Drug Strategy for the period 2009-12 sets the goal to yield concrete and identifiable improvements concerning the knowledge of drugs trafficking. In addition, the EU Drugs Action Plan for 2009-12 defines among others the objec[...]Rapport
FRANÇAIS : Cette «Question spécifique» concerne l'usage concomitant ou consécutif de différentes substances licites et illicites (polyconsommation) chez les adolescents, les jeunes adultes et les usagers problématiques de drogues. Afin de décr[...]Chapitre
FRANÇAIS : La définition générale de la «polytoxicomanie» utilisée par beaucoup d'États membres est la consommation abusive - de façon simultanée ou séquentielle - de plusieurs drogues ou types de drogues par un individu (selon la définition de[...]Rapport
OEDT = EMCDDA ; S. MINOZZI ; L. AMATO ; M. DAVOLI ; M. FERRI ; A. BO ; R. SIMON | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2014Illicit opioid consumption during pregnancy brings with it the risk of an increase in obstetric complications for the mother and a range of potential dangers for the child, both before and after birth. The primary goal when treating opioid depen[...]Rapport
This Selected issue gives a broad overview on the extent of, and available responses to, the problems of pregnant drug users and families that are affected by drug use. In the first part of the report, a description of the available data on the [...]Rapport
OEDT = EMCDDA ; D. THANKI ; J. MATIAS ; P. GRIFFITHS ; A. NOOR ; D. OLSZEWSKI ; R. SIMON ; J. VICENTE | Lisbon : OEDT / EMCDDA | Thematic Papers, ISSN 1725-5767 | 2012This report brings together, for the first time in Europe, an integrated overview of the prevalence of intensive cannabis use, defined as daily or almost daily cannabis use (use on 20 or more days in the month preceding survey). Self-reported da[...]Rapport
Drug overdose is one of the major causes of death among young people in Europe. This paper considers how naloxone - an effective antidote that can reverse opioid intoxication - combined with training in first aid for coping with an overdose for [...]Rapport
G. BURKHART, Responsable de l'équipe de recherche ; FEGERT J. M. ; SCHEPKER R. ; F. KELLER ; LUDOLPH A.G. ; PLENER P. L. ; A. E. WILLIAMSON ; N. VOLMER-BERTHELE ; WENINGER L. E. ; KAPUSTA N. D. ; L. HART-KERKHOFFS | Lisbon : OEDT / EMCDDA | Thematic Papers, ISSN 1725-5767 | 2009This review on indicated prevention adds to the current knowledge and understanding of risk factors in the development of later drug problems and dependence, focusing on the mental health and behavioural problems that develop during childhood. I[...]Rapport
OEDT = EMCDDA ; J. STRANG ; R. McDONALD ; D. HEDRICH ; R. SIMON | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2016This publication examines the case for distributing naloxone, an emergency medication, to people who inject opioids such as heroin and to others who might witness an opioid overdose. Through its capacity to reverse opioid overdose, naloxone can [...]Rapport
M. FRISHER ; A. BALDACCHINO ; I. CROME ; R. BLOOR | Lisbon : OEDT / EMCDDA | Scientific Studies | 2012FRANÇAIS : L'objectif de ce rapport consistait à effectuer une revue de la littérature sur les risques de surdoses mortelles évitables chez les consommateurs d'héroïne. De façon générale, l'état actuel des connaissances montre que plus il y a d[...]Rapport
European Centre for Disease Prevention and Control ; OEDT = EMCDDA | Lisbon : OEDT / EMCDDA | Joint reports | 2023This joint guidance report explores good public health practices that can support effective policies to reduce infections. Common blood-borne viruses in this group include HIV, hepatitis B and hepatitis C. These are mainly spread through the sha[...]Rapport
This manual compiles basic but evidence-based prevention principles, planning rules and evaluation tips. Additionally, it provides related documentation or references for download; it is hoped that this additional material will be particularly u[...]Rapport
This publication is an update of Prevention of substance abuse, published in 2007. Like the previous analysis, it is a translation of a German study that presents a state-of-the-art review of prevention science. Although originally targeted at t[...]Rapport
This publication provides information on best practice in drug prevention at European, national, regional and municipal level. It is a translation of a German study commissioned by the Federal Centre for Health Education, Cologne. While, in some[...]Rapport
OEDT = EMCDDA ; L. MONTANARI ; L. ROYUELA ; I. HASSELBERG ; L. VANDAM | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2021FRANÇAIS : Ce rapport examine en profondeur un large éventail de problèmes en milieu carcéral, notamment la consommation de drogues et ses méfaits, les réponses sanitaires et sociales et l'approvisionnement en drogues. Il note que, si, dans pl[...]Document multimédia
ENGLISH: People in prison are more likely to use drugs than those in the general population. In order to respond to their health and social needs, it is vital to have a sound understanding of the interventions available in prisons and which wor[...]Rapport
FRANÇAIS : On estime qu'environ 635 000 personnes sont détenues dans des institutions carcérales dans l'Union européenne. Des travaux de recherche montrent que les problèmes de drogue sont bien plus répandus au sein de cette population qu'au s[...]Rapport
FRANÇAIS : Cette question spécifique, axée sur les pays européens dans lesquels l'amphétamine ou la méthamphétamine constituent une part importante du problème de la drogue, examine la situation actuelle à la lumière de l'évolution historique d[...]Document texte divers
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; D. THANKI ; E. KALAMARA ; A. NOOR ; L. MONTANARI ; J. VICENTE | Lisbon : OEDT / EMCDDA | 2015Some drug users go on to develop more severe forms of use, defined by the EMCDDA as 'high-risk drug use': 'recurrent drug use that is causing actual harms (negative consequences) to the person (including dependence, but also other health, psycho[...]